Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

NCT02954198 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Immunosuppression

Interventions

DRUG: Tacrolimus
DRUG: Prednisone
DRUG: Mycophenolate mofetil
DRUG: Everolimus

Sponsor

Medical University of South Carolina